Investigation of frailty markers including a novel biomarker panel in patients undergoing emergency laparotomy

Ng, Hwei Jene (2026) Investigation of frailty markers including a novel biomarker panel in patients undergoing emergency laparotomy. PhD thesis, University of Glasgow.

Full text available as:
[thumbnail of 2026NgPhD.pdf] PDF
Download (7MB)

Abstract

Emergency laparotomy (EmLap) is one of the commonest operations performed in the UK, about 30,000 annually. When frailty, a clinical syndrome of increased vulnerability that results from age associated multi-system physiological decline is present, the morbidity and mortality post-EmLap is high. Insights into the mechanisms of frailty are urgently needed to develop interventions and improve outcomes for patients living with frailty undergoing EmLap. This thesis aims to compare the ability of the established pre-operative frailty markers in predicting 30-day morbidity and 30-day and 90-day mortality post-EmLap, develop a robust sample preparation workflow for Ultra High Performance Liquid ChromatographyMass Spectrometry (UHPLC-MS)-based metabolomic analysis of plasma samples from EmLap patients, explore novel metabolites associated with frailty and their changes in peri-operative period and analyse the influence of peri-operative frailty on quality of life (QoL) post-EmLap.

A prospective, single centred, observational study was conducted on 150 patients ≥40 years of age who underwent EmLap from May 2022 to April 2023 according to the established National Emergency Laparotomy Audit (NELA) criteria with 3 months follow up. Morbidity and mortality were assessed and compared using established frailty markers such as sarcopenia (psoas muscle measurement on CT scan), nutrition (Malnutrition Universal Screening Tool (MUST) score), cognition (Abbreviated Mental Test score) and the Rockwood Clinical Frailty Score (CFS score >4 as frail). When determining novel biomarkers, plasma samples were collected pre-operatively and post-EmLap day 1, 7, 30 and 90 and metabolic signatures correlated to frailty status were determined using UHPLC-MS-based metabolomics. Finally, quality of life was assessed using the EQ-5D-5L questionnaire on the 30- and 90-day follow-up. The patients were divided into groups of frail and non-frail, and the Mann-Whitney test was used for comparison analysis. Univariate analysis using Chi-square test or Fisher’s exact test followed by multivariable analysis using logistic regression were performed. The metabolomic data collected across the five time points were analysed using Principal Component Canonical Variance Analysis (PC-CVA) and the identified metabolites were classified with Multivariate Marginal Hierarchical Cluster Analysis (MMHCA) and univariate generalised linear model (GLM) was used to analyse the metabolites differing between the non-frail to mortality group.

Of the 150 recruited patients, 55% were female with median age of 69 years and the 90-day mortality was 13.3%. In this cohort, 10% were living with frailty pre-EmLap and 10.1% became frail post-EmLap. Across the 5 peri-EmLap time points, distinct metabolites differed between groups (ANOVA FDR ≤ 0.05), largely associated with subsequent mortality in patients who were non-frail pre-operatively rather than subsequent frailty. MMHCA revealed discrete clusters of metabolites that suggested post-EmLap metabolic dysregulation while GLM detected 26 metabolites (from biochemical class of amino acid, acylcarnitine, peptides and nucleoside metabolism) that were associated with 90-day mortality. Quality of life was found to be worse in the frail group but there was a positive trajectory of recovery over the follow-up period.

In this study, the established frailty markers (CFS, sarcopenia, cognition and nutrition) were not associated with 30-day morbidity and 30 or 90-day mortality. This finding needs to be interpreted with caution due to small sample size. Despite no metabolites identified that predicted frailty, metabolites associated with postoperative mortality were identified in EmLap patients using UHPLC-MS-based metabolomics. These metabolites may be candidate biomarkers for further investigation that may offer a promising approach for assessing vulnerability in emergency setting. Quality of life findings also affirmed that recovery is possible even among frail patients, reinforcing the value of integrated, multidisciplinary post-operative care. Further studies with larger patient cohorts are required to validate these findings.

Item Type: Thesis (PhD)
Qualification Level: Doctoral
Additional Information: Supported by funding from the Royal of College of Surgeons of Edinburgh, Association of Surgeons of Great Britain and Ireland, and GUTS UK!
Subjects: R Medicine > R Medicine (General)
Colleges/Schools: College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Funder's Name: Royal of College of Surgeons of Edinburgh, Association of Surgeons of Great Britain and Ireland, GUTS UK!
Supervisor's Name: Moug, Professor Susan and Quasim, Professor Tara
Date of Award: 2026
Depositing User: Theses Team
Unique ID: glathesis:2026-86386
Copyright: Copyright of this thesis is held by the author.
Date Deposited: 20 Nov 2026 16:17
Last Modified: 20 Nov 2026 16:17
URI: https://theses.gla.ac.uk/id/eprint/86386
Related URLs:

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year